News articles about Cerner Corporation (NASDAQ:CERN) have trended somewhat positive on Tuesday, Accern reports. The research group identifies positive and negative news coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Cerner Corporation earned a coverage optimism score of 0.16 on Accern’s scale. Accern also assigned news stories about the company an impact score of 47.619586366792 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.
These are some of the media headlines that may have effected Accern Sentiment’s analysis:
- Worldwide Digital Health Market Segment 2017-2022 – Agfa-Gevaert, Cerner Corporation (mynewsdesk.com)
- Cerner Corporation (CERN) Short Interest Update (americanbankingnews.com)
- Cerner Corporation (CERN) Expected to Post Quarterly Sales of $1.33 Billion (americanbankingnews.com)
- Worldwide Hospital Information Systems (HIS) Market Segment 2017-2022 – Cerner Corp., Epic Systems Corp. (mynewsdesk.com)
- Cerner Stock Sees Short Interest Fall 14.6% (thestreet.com)
A number of research firms recently weighed in on CERN. Royal Bank Of Canada restated a “buy” rating on shares of Cerner Corporation in a report on Wednesday, October 25th. Jefferies Group LLC restated a “buy” rating on shares of Cerner Corporation in a report on Sunday, October 29th. Zacks Investment Research cut Cerner Corporation from a “buy” rating to a “sell” rating in a report on Tuesday, October 31st. BidaskClub lowered Cerner Corporation from a “buy” rating to a “hold” rating in a research note on Tuesday, July 25th. Finally, Stifel Nicolaus restated a “hold” rating and set a $69.00 target price on shares of Cerner Corporation in a research note on Friday, July 28th. One equities research analyst has rated the stock with a sell rating, fourteen have issued a hold rating and nine have assigned a buy rating to the company’s stock. The company has an average rating of “Hold” and an average price target of $69.79.
Shares of Cerner Corporation (CERN) traded down $0.41 during midday trading on Tuesday, reaching $65.06. 207,866 shares of the company traded hands, compared to its average volume of 2,380,399. Cerner Corporation has a fifty-two week low of $47.01 and a fifty-two week high of $73.86. The firm has a market capitalization of $21,710.02, a price-to-earnings ratio of 28.90, a P/E/G ratio of 2.10 and a beta of 0.93. The company has a debt-to-equity ratio of 0.11, a current ratio of 2.77 and a quick ratio of 2.75.
Cerner Corporation (NASDAQ:CERN) last announced its quarterly earnings data on Thursday, October 26th. The company reported $0.61 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.62 by ($0.01). Cerner Corporation had a net margin of 13.37% and a return on equity of 18.03%. The business had revenue of $1.28 billion during the quarter, compared to analyst estimates of $1.29 billion. During the same quarter in the prior year, the company earned $0.59 earnings per share. The company’s quarterly revenue was up 7.7% on a year-over-year basis. equities research analysts anticipate that Cerner Corporation will post 2.26 earnings per share for the current fiscal year.
In other Cerner Corporation news, COO Michael Nill sold 99,470 shares of the stock in a transaction on Wednesday, September 13th. The shares were sold at an average price of $70.45, for a total value of $7,007,661.50. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Chairman Clifford W. Illig sold 4,000 shares of the stock in a transaction on Tuesday, November 7th. The stock was sold at an average price of $65.96, for a total transaction of $263,840.00. Following the completion of the sale, the chairman now owns 1,229,719 shares in the company, valued at $81,112,265.24. The disclosure for this sale can be found here. Insiders sold 257,470 shares of company stock worth $17,695,482 over the last 90 days. 13.20% of the stock is currently owned by company insiders.
About Cerner Corporation
Cerner Corporation (Cerner) is a supplier of healthcare information technology (HCIT). The Company offers a range of intelligent solutions and services that support the clinical, financial and operational needs of organizations of all sizes. The Company’s segments include Domestic and Global. The Domestic segment includes revenue contributions and expenditures associated with business activity in the United States.
Receive News & Ratings for Cerner Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner Corporation and related companies with MarketBeat.com's FREE daily email newsletter.